319 results
Page 6 of 16
425
aueqgr3y
27 Oct 22
Business combination disclosure
7:15am
8-K
7fi9xvp
27 Oct 22
Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting
7:13am
425
eytln7 j91p5tmgrnyfv
26 Oct 22
Business combination disclosure
5:17pm
8-K
EX-99.1
kamietil
26 Oct 22
Regulation FD Disclosure
5:14pm
8-K
b25e0yr4vdhnwbk6
26 Oct 22
Regulation FD Disclosure
5:14pm
425
4i4n rgqtyjny
26 Oct 22
Business combination disclosure
5:10pm
8-K
yvbr1n k0pm9xjni
26 Oct 22
Regulation FD Disclosure
5:08pm
8-K
EX-99.1
xnple0tp
26 Oct 22
Regulation FD Disclosure
5:08pm
425
xjmjp9j
24 Oct 22
Business combination disclosure
8:00am
8-K
jq0kxatbnb22js29wx
24 Oct 22
Entry into a Material Definitive Agreement
7:59am
425
qy7e4l4ib7lvai5yct3
17 Oct 22
Business combination disclosure
4:03pm
8-K
hgc8gv g5a9
17 Oct 22
Clinical trial anticipated to begin in late 2022
4:02pm
425
aj4rtg cf6fauih7v
13 Oct 22
Business combination disclosure
4:03pm
8-K
3hoa49k
13 Oct 22
Kineta to Present Anti-CD27 Agonist Preclinical Program at AACR Conference on Tumor Immunology and Immunotherapy
4:01pm
425
kk1qv juh7ftisga
11 Oct 22
Business combination disclosure
8:02am
8-K
wl2opd56ri72
11 Oct 22
Kineta Announces Participation in Upcoming October 2022 Investor Conferences
8:00am
425
zmx9bx38
4 Oct 22
Business combination disclosure
4:04pm